Teleflex Incorporated (TFX) support and resistance · P/E 2083, rev $3.05B
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
This page maps Teleflex Incorporated (TFX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TFX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TFX quote page for the session range and the stock page for the full model.
Not investment advice.